Datapoint: Centene Completes MagellanRx Sale

Centene Corp. last week completed its sale of pharmacy benefit manager MagellanRx to Prime Therapeutics, the PBM jointly owned by 19 Blues affiliates. Centene first acquired MagellanRx in January 2022, following its purchase of Magellan Health. The company is also in the process of selling off another Magellan asset, Magellan Specialty Health, to Evolent Health as it continues a value creation plan spearheaded by CEO Sarah London. Centene is currently the fourth-largest insurer in the U.S., serving 17,144,851 lives.

Source: AIS’s Directory of Health Plans

0 Comments
AIS Health Staff

AIS Health Staff

Related Posts

businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
February 8

Datapoint: CMS Announces Special Enrollment Period for PHE Medicaid Coverage Losses

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
February 7

Datapoint: Gilead Scores Broader Breast Cancer Nod for Trodelvy

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
February 6

Datapoint: New Mexico Cancels Medicaid RFP

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today